Director Xinhang Yu has been engaged in medical oncology for nearly 30 years, focusing on molecular diagnosis and individualized treatment of malignant lymphoma. She has developed standardized diagnosis and treatment of lymphoma in the Department of Lymphoma, Peking University Cancer Hospital, and has rich clinical experience in molecular targeted drug therapy, neoadjuvant therapy and treatment of toxic and side effects of chemotherapy. National and provincial papers published more than 10.